Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Cosmetics ; 10(2):61, 2023.
Article in English | ProQuest Central | ID: covidwho-2305767
The Coronavirus Crisis and Challenges to Social Development: Global Perspectives ; : 237-249, 2022.
Article in English | Scopus | ID: covidwho-2296106
Annals of Burns & Fire Disasters ; 35(4):347-347, 2022.
Article in English | Academic Search Complete | ID: covidwho-2167298
Australian Journal of Social Issues ; 2022.
Article in English | Web of Science | ID: covidwho-2013332
Wiener Klinische Wochenschrift ; 133(23/24):1237-1317, 2021.
Article in English | GIM | ID: covidwho-1887503
Cureus ; 14(4): e24126, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1847675


As the onset of novel variants of the severe acute respiratory syndrome coronavirus 2 virus pushes policy-makers to push widespread vaccination efforts, it is likely that an increased number of severe cutaneous adverse reactions (SCARs) will present. Therefore, it is important to understand the presentation of possible SCARs. However, data are limited regarding which SCARs are most likely to be found following vaccination, and specific presentations in certain demographic groups, such as postmenopausal women, remain widely unknown. Here, we present the case of a 73-year-old female with no medical history or allergies presenting with a unique reaction of systemic bullous pemphigoid following the Moderna mRNA-1273 vaccine. To our knowledge at the time of this writing, based on a thorough review of the literature using PubMed, no such cases exist following the Moderna vaccine in the United States in elderly, postmenopausal women. We present a brief discussion on the presentation and management to hopefully alleviate future morbidity from similar reactions with increased distribution of the vaccine.

Chelonian Conservation and Biology ; 20(2):300-303, 2021.
Article in English | ProQuest Central | ID: covidwho-1598344